Article Versions Notes

Jamal F, Elshaer A, Odeh NB, Alatout MH, Shahin T, Worden AR, Albunni HN, Lizaola-Mayo BC, Jayasekera CR, Chascsa DMH, et al. Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis. Life. 2025; 15(8):1306. https://doi.org/10.3390/life15081306

Jamal, Fares, Amani Elshaer, Nour B. Odeh, Mayar H. Alatout, Tala Shahin, Astin R. Worden, Hashem N. Albunni, Blanca C. Lizaola-Mayo, Channa R. Jayasekera, David M. H. Chascsa, and et al. 2025. "Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis" Life 15, no. 8: 1306. https://doi.org/10.3390/life15081306

Jamal, F., Elshaer, A., Odeh, N. B., Alatout, M. H., Shahin, T., Worden, A. R., Albunni, H. N., Lizaola-Mayo, B. C., Jayasekera, C. R., Chascsa, D. M. H., Vargas, H. E., & Aqel, B. A. (2025). Resmetirom in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis. Life, 15(8), 1306. https://doi.org/10.3390/life15081306